Use of corticosteroids and other immunosuppressant medications Inherited neutrophil deficits and/or immune deficient conditions

Size: px
Start display at page:

Download "Use of corticosteroids and other immunosuppressant medications Inherited neutrophil deficits and/or immune deficient conditions"

Transcription

1 Develped in cllabratin with the Wund Care Champins, Wund Care Specialists, Enterstmal Nurses, and Suth West Reginal Wund Care Prgram (SWRWCP) members frm Lng Term Care Hmes, Hspitals, and Suth West CCAC cntracted Cmmunity Nursing Agencies in the Suth West Lcal Health Integratin Netwrk. Title Guideline: The Assessment and Management f Bacterial Burden in Acute and Chrnic Wunds Backgrund As per the cncept f Preparing the Wund Bed, lcal factrs must be assessed and managed in rder t prmte timely and rderly clsure f wunds. This includes cnsideratin f increased bacterial burden and/r wund infectin and persistent inflammatin 1 Assessment f infectin needs t be f the whle persn, and specifically the persn s ability t resist infectin, as: Infectin = dse x virulence Hst resistance Whereas: Dse = the amunt f micrrganisms which is sufficient t cause infectin. It is generally accepted that rganisms in a quantity greater than 10 6 (the dse) will nt nly impair healing, but will prduce sufficient txins and prtelytic enzymes t harm living tissue 10 Virulence = the cmpetence f a nxius agent t prduce its effect. Different bacteria have different virulent prperties, s that a mre virulent species may have mre deleterius effects n the wund than the actual quantity f bacteria present Hst resistance = the ability f an individual t withstand the nxius influence. Systemic and lcal factrs can increase the risk f infectin: Systemic Factrs Lcal Factrs Malnutritin Edema Vascular disease and/r diabetes mellitus Use f crticsterids and ther immunsuppressant medicatins Inherited neutrphil deficits and/r immune deficient cnditins Prir surgery r raditherapy Alchlism Rheumatid arthritis Large wund area and/r depth High degree f wund chrnicity Anatmic lcatin, i.e. near anus Presence f freign bdies and/r necrtic tissue in the wund Mechanism f injury, i.e. trauma r perfrated viscus High degree f cntaminatin Reduced tissue perfusin Lng r cntaminated surgery All wunds cntain bacteria at levels ranging frm cntaminatin t systemic infectin (see Definitins f Bacterial Burden in Chrnic Wunds ). It is the interpretatin f the clinical signs f increased bacterial burden/infectin that directs treatment (if required) (see Biburden Assessment Tl and Interpretatin ). There is NO single scientific test t definitively diagnse infectin Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

2 The rle f bifilms: Bifilms are cmmunities f bacteria/fungi that c-exist in a prtective matrix n the surface f sme chrnic wunds 5 The matrix prtects the bacteria/fungi living within it frm external threats, like tpical antimicrbials and wund cleansing and superficial debriding measures They are present in up 60% f chrnic wunds, and may be respnsible fr persistent inflammatin, which delays wund clsure 4 Sharp debridement fllwed immediately by the applicatin f a brad spectrum tpical antimicrbial (repeated as necessary) is the nly way t successfully remve and prevent bifilm recnstitutin Strategies t reduce risk f wund infectin: Adhere t hand washing prtcls befre and after dressing changes Remember that dressings supplies are fr single persn use nly, i.e. avid sharing dressings between peple Dressings pre-packaged fr single use are intended t be used in that manner, i.e. nt accessed and the remaining dressing fragments saved fr future use. NOTE: fr thse with ACUTE wunds receiving wund care, it is realized that in reality dressings are being accessed frm sterile, single use packaging, used, and that the remaining dressing fragments are being used in future dressing changes. Fr ACUTE wund care, this may be acceptable, if yur rganizatin s indicates in their plicies and if the fllwing criteria are met: The packaging is pened using aseptic technique The dressing is cut using sterile frceps and scissrs The remaining dressing pieces are placed int a sterile C+S cntainer, using aseptic technique, that has been labelled with the persn s name, the date, and the name f the dressing The remaining dressing pieces are accessed frm the C+S cntainer in the future using aseptic technique After tw weeks in the C+S cntainer, the cntainer and its remaining cntents are discarded Fr thse with CHRONIC wunds, althugh single use f prepackaged dressings is indicated by dressing manufacturers, it t is realized that in reality this may nt be happening, i.e. remaining dressing fragments are being saved fr future use. NOTE: fr thse with CHRONIC wunds receiving wund care, it may be apprpriate t re-use dressing fragments, if yur rganizatin s indicates in their plicies and if the fllwing criteria are met: The packaging is initially pened using aseptic Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

3 technique The dressing is cut using clean instruments The remaining dressing pieces are placed int a sterile C+S cntainer that has been labelled with the persn s name, the date, and the name f the dressing The remaining dressing pieces are accessed frm the C+S cntainer in the future using clean technique After tw weeks in the C+S cntainer, the cntainer and its remaining cntents are discarded Single use saline r sterile water bttles (110mL) are used in their entirety at each dressing change, i.e. they are nt recapped and used fr subsequent dressing changes, nr are they shared between peple Fr thse accessing larger cntainers f saline r sterile water, i.e. larger than 115mL, if accessed in a sterile manner, these bttles may be re-used fr the same persn fr a perid f 24 hurs, befre they are required t be discarded. The slutin must be dated and labelled with the persn s name when pened, and may be stred at rm temperature with the cap secured Assess and treat acute wunds, i.e. wunds that are less than fur weeks ld, using sterile (aseptic) technique. Thse with neutrphil deficits and/r immune deficiency and wh have chrnic wunds, may als benefit frm aseptic technique Assess and treat chrnic wunds, i.e. wunds that are greater than fur weeks ld, using clean technique Take nly the supplies needed fr the single dressing change t the persn s bedside r int the persn s hme, as such supplies cannt be returned t the dressing supply rm/shelf/cart, etc. and MUST BE DISCARDED fr infectin cntrl reasns If supplies are being stred in a persn s hme, they must be stred accrding t manufacturer s guidelines and in a lcatin that is inaccessible t children and pets Remve nn-viable tissue frm the wund surface, as apprpriate, as it prvides an pprtunity fr micrbial grwth 6 [see Guideline and Prcedures: Wund Debridement (excluding cnservative sharp debridement) and/r Guideline and Prcedure: Cnservative Sharp Wund Debridement (CSWD )] Optimize the misture balance f the wund bed (in healable wunds) 7, as dry wund beds may develp micrscpic cracks that may be prtals f entry fr bacteria Cnsider the use f tpical antimicrbials in high-risk individuals/wunds t prevent wund infectin 7, i.e.: Thse with a histry f delayed healing/infectin; Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

4 Indicatins Guideline Thse with wunds in anatmical lcatins that increase the risk f cntaminatin, i.e. the sacrum; Wunds f 4+ weeks duratin at initial presentatin, that have n visible signs f healing r with signs f deteriratin; Thse with pathlgies r activities that may cmprmise immunity, i.e. thse with diabetes and prly cntrlled bld sugars, smking, alchl abuse, etc.; In areas f significantly cmprmised bld flw where healing is unlikely, and; T reduce dr that may be affecting quality f life. This guideline is intended t be used by frnt line registered health care prviders, t guide their assessment and management f wund bacterial burden/infectin in thse individuals presenting with a wund. NOTE: The assessment and management f a persn s wund fr bacterial burden/infectin is but ne part f the hlistic assessment and management f individuals admitted with/presenting with a wund. Assessment 1. Review the persn s medical recrds fr the fllwing infrmatin, as it may help yu t determine if the persn s wund is critically clnized, r has spreading r systemic infectin: a. Histry f stalled r slw wund clsure b. Histry f increasing exudate/dr c. Presence f lcalized edema d. Increase in wund related pain experience e. New wund breakdwn r satellite lesins f. Histry f lymphangitis, general malaise, fever, rigrs, chills, hyptensin, rgan failure 2. Review the persn s medical recrds fr the fllwing infrmatin: a. Healability status (see the Determining Healability Tl ) b. Infrmatin re the size, lcatin, and characteristics f the wund t be assessed/debrided/dressed, as this will help yu anticipate supplies needed c. Current wund infectin treatment and respnse d. Current wund care rders Planning 1. Expected utcmes: a. Infrmatin frm the persn s chart, the persn and/r their substitute decisin maker (SDM)/pwer f attrney fr persnal care (POA C), and yur assessment allws fr the determinatin f the level f bacterial burden present in/n the wund (as per the Biburden Assessment Tl ), and as such the selectin f the mst apprpriate interventins b. Infrmatin btained will allw fr the determinatin f Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

5 whether r nt the wund is psitively respnding t bacterial burden/infectin management measures, i.e. the clinical signs f critical clnizatin, spreading infectin, and systemic infectin (see: Definitins f Bacterial Burden in Chrnic Wunds ) are disappearing/reslving c. Registered nursing staff, in cllabratin with the individual with the wund and/r their SDM/POA C, and ther invlved health care disciplines, are able t use the assessment infrmatin t initiate/mdify and implement an apprpriate persn-centered, interdisciplinary plan f care which cntains clear directins t staff and thers wh are prviding the persn with direct care 2. Explain the prcedure and its purpse t the persn and/r their SDM/POA C, and btain infrmed implied/verbal cnsent 3. Assess the need fr pre-prcedure pain medicatin remval f dressings, the dressing prcedure itself, and/r debridement may be painful. If required, the persn must be alltted enugh time t achieve the drug s peak effect BEFORE initiating the dressing change/debridement Implementatin 1. Prvide fr privacy and ensure the persn is in a cmfrtable psitin t facilitate assessment f the wund and fr the wund debridement/dressing prcedure 2. Wash yur hands and attend t the persn with yur assessment tls and anticipated debridement and/r wund dressing supplies 3. If the persn is in bed, raise the bed (if yu are s able t) t an apprpriate ergnmic psitin t allw fr the wund assessment and treatment while preventing self-injury 4. Ensure adequate lighting 5. Dn clean dispsable glves and additinal persnal prtective equipment (PPE), i.e. gwn, gggles, and/r mask as required if risk fr splash back r spray exists 6. Remve the existing wund dressing as per the manufacturer s instructins. Observe the dressing fr the appearance f the drainage f n the dressing. Assess fr dr 7. Dispse f the siled dressings in the prper receptacle and remve and dispse f yur siled glves 8. Apply new clean dispsable glves and cleanse the wund as rdered r as per the SWRWCP s Dressing Selectin and Cleansing Enabler HEALABLE WOUNDS r the SWRWCP s Dressing Selectin and Cleansing Enabler MAINTENANCE/NON-HEALABLE WOUNDS 9. Gently pat the wund bed dry (if required) and dry the surrunding skin with gauze 10. If indicated, and if yu have the knwledge, skill, judgment, and authrity, cnservatively sharp debride any necrtic tissue present Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

6 and re-cleanse the wund as abve [see: Guideline and Prcedure: Cnservative Sharp Wund Debridement (CSWD) ] 11. Assess the wund using the NPUAP PUSH Tl 3.0 (see Prcedure: NPUAP PUSH Tl 3.0 ) 12. Observe fr clinical signs f increased bacterial burden/infectin using the Biburden Assessment Tl, determining the level f risk, i.e. clnized, critically clnized, spreading infectin, r systemic infectin, as nted n the Tl itself 13. Crss reference the bacterial burden risk level with the dcument Definitins f Bacterial Burden in Chrnic Wunds, as this will suggest apprpriate clinical interventins based n level f risk, i.e. Bacterial Burden Level Clinical Interventins Cntaminated Mnitr and risk reductin* Clnized Mnitr and risk reductin* Tpical antimicrbials Critical Clnizatin Effective debridement Tpical antimicrbials Spreading Infectin Effective debridement Systemic antibitics Tpical antimicrbials Effective debridement Systemic Infectin Systemic antibitics Rule ut ther infectin surces *Risk reductin suggestins can be fund in the Backgrund sectin f this dcument 14. If the use f tpical antimicrbials are indicated, see the fllwing resurces (fund n the Prgram s website: t infrm yur chice f antimicrbial(s). NOTE: antimicrbials shuld be trialed fr a day perid (a Tw Week Challenge ), and if the wund shws n imprvement, the persn and the wund shuld be re-evaluated, a wund swab shuld be cnsidered, and the persn shuld be assessed by their primary care prvider t determine if systemic antibitic treatment is warranted (see Criteria fr Interdisciplinary Referrals ). If after tw weeks the wund is prgressing twards clsure yet still exhibits signs f infectin, cntinue the use f the antimicrbial dressing fr anther tw weeks. If the persn has had an antimicrbial dressing n fr lnger than fur weeks, review the dressing regimen and cnsider a referral t Enterstmal (ET) Nurse r Wund Care Specialist (WCS) fr further discussin f the management plan (see Criteria fr Interdisciplinary Referrals ): a. Safest Tpical Antimicrbials fr Use in Wund Care b. Tpical Antimicrbials fr Selective Use in Wund Care c. Tpical Antimicrbials fr Cautinary Use in Wund Care NOTE: STOP using tpical antimicrbials when the signs f infectin reslve, when the wund starts t prgress twards clsure, and/r if the persn experiences an antimicrbial Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

7 related adverse event 15. Antimicrbial dressings shuld be selected based n their ability regarding: a. Absrbency and ability t be used with highly exudating r lw exudating wunds b. Cnfrmability t the wund surface i.e. the mre that the dressing matches the cnturs f the wund surface and directly cntacts it, the better the antimicrbial effect c. Management f dr and/r pain d. Activity against the specific bacteria in the wund e. Sufficient levels f the agent t achieve bacterial kill as ppsed t bacterial inhibitin (and within what length f time) f. Cyttxicity, i.e. are the cmpnents f the dressing likely t damage healthy living cells g. Allergenicity h. What the persn can tlerate i. The cst f the dressing vs the frequency f dressing changes 16. If debridement is indicated see Guideline and Prcedures: Wund Debridement (excluding cnservative sharp debridement), Guideline and Prcedure: Cnservative Sharp Wund Debridement (CSWD), and/r cnsider a referral t a general surgen r ther such prfessinal skilled in sharp debridement (and wh has the authrity t perfrm such a prcedure), i.e. see Criteria fr Interdisciplinary Referrals NOTE: aggressive debridement f slugh and the underlying tissue may disrupt the bacterial burden and suppress bifilm regrwth 8. Debridement shuld be fllwed by wund cleansing (see #19) and applicatin f an antimicrbial dressing that is apprpriate fr the clinical indicatins (i.e. exudate and dr management), as well as safe fr and acceptable fr the persn with the wund. See: a. Safest Tpical Antimicrbials fr Use in Wund Care b. Tpical Antimicrbials fr Selective Use in Wund Care c. Tpical Antimicrbials fr Cautinary Use in Wund Care 17. If systemic antibitics are indicated, refer the persn t their primary care prvider fr assessment and cnsideratin f systemic antibitics (see Criteria fr Interdisciplinary Referrals ). Systemic antibitics shuld be used in additin t debridement and the use f tpical antimicrbials (see #19 and #20). Prescribing prfessinals must take int cnsideratin the fllwing when chsing an antibitic 10 : a. The mst likely r cnfirmed antibitic susceptibilities f the suspected r knwn pathgen(s). NOTE: in wunds less than 4 weeks ld, the mst cmmn pathgens are gram +. In wunds greater than 4 weeks ld, the mst Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

8 cmmn pathgens are gram +, gram and anaerbes. If empirical treatment is necessary, start with an apprpriate brad-spectrum antibitic and when susceptibilities becme available, if the wund is nt respnding t the afrementined treatment, cnsider switching t a narrwer-spectrum agent(s) b. The persn with the wund, i.e. allergies, ptential interactins with current medicatins, cmrbidities, ability/willingness t cmply with treatment c. Guidelines fr the treatment f infectin in specific wund types, i.e. diabetic ft ulcers d. Severity f the infectin (NOTE: IV antibitics are usually reserved fr serius r life-threatening infectins) e. Availability, cst and safety 18. Wund swab cultures ften tell yu what micrbes are present n the surface f the wund, which may nt be the same as thse causing infectin deeper in the wund, ften making the results incnclusive. It is apprpriate t swab a wund (using the Levine Technique, see Prcedure: Wund Swabbing Using the Levine Technique ) 10 : a. When yu have an acute wund with clinical signs f infectin b. When yu have a chrnic wund with signs f spreading r systemic infectin c. When yu have a chrnic wund that has nt respnded t r is deterirating despite antimicrbial treatment d. As required by lcal surveillance prtcls 19. Fr thse with spreading and systemic infectin, it is imprtant t ptimize the hst respnse s that their immune system may best fight the infectin, i.e. ptimize the management f cmrbidities, minimize risk factrs fr infectin, ptimize nutritin and hydratin, and treat ther surces f infectin 20. Once yu have prvided wund care, remve yur glves and ther PPE and dispse f them and f any siled supplies in the apprpriate receptacle 21. Dispse f any used sharps in a sharps cntainer 22. Clean reusable equipment/surfaces tuched during the prcedure with sap and water r detergent wipes and dry thrughly t prevent crss infectin, returning reusable equipment t the apprpriate places 23. Wash yur hands 24. Assist the persn t a cmfrtable psitin if required, and assess fr any cncerns 25. Lwer the persn s bed t an apprpriate height (if applicable), and ensure the persn s safety, i.e. apply side rails, persnal alarms, restraints, etc. as per the persn s care plan/medical rders 26. Discuss yur findings f the assessment and yur thughts re the presence/absence f signs f infectin with the persn and/r their Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

9 References SDM/POA C and implement referrals and further interventins as indicated 27. Share yur wund assessment and interventin implementatin findings/utcmes with the interdisciplinary members f the persn s wund care team 28. Cmplete/update and implement an apprpriate, persn-centered, interdisciplinary plan f care, based n yur hlistic assessment and interventins, and as per yur rganizatin s plicy Evaluatin 1. Unexpected utcmes: a. The persn reprts prly managed pain assciated with this prcedure b. There is an increase in clinical signs f wund infectin, despite implementatin f apprpriate interventins 2. Re-assess the wund using the NPUAP PUSH Tl 3.0 at a minimum f weekly t ensure yur bacterial balance interventins were effective, and t determine if cnsideratin f ther/additinal frms f infectin management interventins are necessary 1. Sibbald RG, Orsted HL, Cutts PM, et al. Best practice recmmendatins fr preparing the wund bed: Update Wund Care Canada. 2006;4(1): Cutting KF, Harding KG. Criteria fr identifying wund infectin. Jurnal f Wund Care. 1994;3: Caput GM, Jshi N, Weitekamp MR. Ft infectins in patients with diabetes. Am Fam Phys. 1997;56: James GA, Swgger E, Wlctt R, et al. Bifilms in chrnic wunds. Wund repair Regeneratin. 2008;16(1): Wlctt RD, Rhads DD. A study f bifilm-based wund management in subjects with critical limb ischemia. J Wund Care. 2008;17(4): Penhallw K. A review f studies that examine the impact f infectin n the nrmal wund-healing prcess. J Wund Care. 2005;14(3): Wunds UK Best Practice Statement. The use f tpical antimicrbial agents in wund management (3 rd edn). Lndn: Wunds UK, Accessed at: 8. Schultz G. Understanding bifilm-based wund care: What yu need t knw. Wunds Internatinal webcast Accessed at 9. Wrld Unin f Wund Healing Sciety Principles f Best Practice Cnsensus. Wund Infectin in Clinical Practice. Lndn: WUWHS, Accessed at: _31.pdf 10. W KY, Sibbald RG. A crss-sectinal validatin study f using NERDS and STONEES t assess bacterial burden. Ostmy Wund Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

10 Related Tls (NOTE: these tls and their instructins can be fund n the SWRWCP s website: swrwundcareprgram.ca) Management. 2009;55(8): Definitins f Bacterial Burden in Chrnic Wunds Biburden Assessment Tl and Interpretatin Determining Healability Tl SWRWCP s Dressing Selectin and Cleansing Enabler HEALABLE WOUNDS SWRWCP s Dressing Selectin and Cleansing Enabler MAINTENANCE/NON-HEALABLE WOUNDS Guideline and Prcedure: Cnservative Sharp Wund Debridement (CSWD) NPUAP PUSH Tl 3.0 Prcedure: NPUAP PUSH Tl 3.0 Safest Tpical Antimicrbials fr Use in Wund Care Tpical Antimicrbials fr Selective Use in Wund Care Tpical Antimicrbials fr Cautinary Use in Wund Care Guideline and Prcedures: Wund Debridement (excluding cnservative sharp debridement) Criteria fr Interdisciplinary Referrals Prcedure: Wund Swabbing Using the Levine Technique Infectin Guide Suth West Reginal Wund Care Prgram Last Updated March 17,

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered

More information

BLOOD BORNE PATHOGENS

BLOOD BORNE PATHOGENS BLOOD BORNE PATHOGENS GALVESTON ISD ANNUAL TRAINING 2018-2019 Galvestn Independent Schl District Special Prgrams/ECH Health Services Required Training Ò Training is required by the Texas Department f Health

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.

More information

Infection Control. Three Ways Germs Are Spread Germs are spread in the environment three ways: direct contact, indirect contact, and droplet spread.

Infection Control. Three Ways Germs Are Spread Germs are spread in the environment three ways: direct contact, indirect contact, and droplet spread. Infectin Cntrl Infectin cntrl is preventing the spread f germs that cause illness and infectin. Infectin cntrl starts with understanding germs and hw they are spread. Abut Germs Everyne cmes in cntact

More information

H1N1 Influenza 09 Guidance for Residential Aged Care

H1N1 Influenza 09 Guidance for Residential Aged Care H1N1 Influenza 09 Guidance fr Residential Aged Care 11 June 2009 As knwledge abut H1N1 Influenza 09 develps, further advice will be prvided. Please check www.healthemergency.gv.au fr the latest infrmatin.

More information

Infection Control Guidelines for Cabin Crew Members on Commercial Aircraft

Infection Control Guidelines for Cabin Crew Members on Commercial Aircraft Infectin Cntrl Guidelines fr Cabin Crew Members n Cmmercial Aircraft PURPOSE These guidelines prvide cabin crew members (flight attendants) with practical measures t prtect themselves, passengers, and

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards

More information

I am having a Rotator Cuff Repair

I am having a Rotator Cuff Repair I am having a Rtatr Cuff Repair A rtatr cuff repair is surgery t repair a trn tendn in the shulder. The rtatr cuff is a grup f muscles and tendns that frm a cuff ver the shulder jint. The muscles and tendns

More information

DFU Staging Procedure South West Regional Wound Care Program Last Updated April

DFU Staging Procedure South West Regional Wound Care Program Last Updated April Developed in collaboration with the Wound Care Champions, Wound Care Specialists, Enterostomal Nurses, and South West Regional Wound Care Program (SWRWCP) members from Long Term Care Homes, Hospitals,

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS 1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics

More information

Year 1 MBChB Clinical Skills Session Blood Glucose Monitoring

Year 1 MBChB Clinical Skills Session Blood Glucose Monitoring Year 1 MBChB Clinical Skills Sessin Bld Glucse Mnitring Reviewed & ratified by: Dr V Taylr-Jnes, Cnsultant Anaesthetist Ms C Tierney, HARC Elements discussed with Ms Lesley Lamen, Diabetic Nurse Specialist

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Methadone Maintenance Treatment for Opioid Dependence

Methadone Maintenance Treatment for Opioid Dependence POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

Percutaneous Nephrolithotomy (PCNL)

Percutaneous Nephrolithotomy (PCNL) Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this

More information

Hospital Preparedness Checklist

Hospital Preparedness Checklist Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been

More information

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

PSYCHOSEXUAL ASSESSMENTS for Children and Adolescents with Problematic Sexual Behavior. Who is qualified to conduct a psychosexual evaluation?

PSYCHOSEXUAL ASSESSMENTS for Children and Adolescents with Problematic Sexual Behavior. Who is qualified to conduct a psychosexual evaluation? PSYCHOSEXUAL ASSESSMENTS fr Children and Adlescents with Prblematic Sexual Behavir When a child r adlescent is suspected r bserved t have engaged in what may be sexually inapprpriate r sexually aggressive

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

Injury, Incident & Illness Procedure

Injury, Incident & Illness Procedure Injury, Incident & Illness Prcedure Injury / Incident Includes any child, adult, r emplyee injured n site. A first aid kit will be available at all times. It will be maintained in accrdance with criterin

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth. DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

Ontario 2018 provincial election issues backgrounder

Ontario 2018 provincial election issues backgrounder Ontari 2018 prvincial electin issues backgrunder Dietitians f Canada Pririties May 2018 Access t dietitians in Ontari s health system Diet is the #1 risk factr fr chrnic diseases that cst Ontari $90 billin

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

STAKEHOLDER IN-DEPTH INTERVIEW GUIDE

STAKEHOLDER IN-DEPTH INTERVIEW GUIDE STAKEHOLDER IN-DEPTH INTERVIEW GUIDE PURPOSE The Stakehlder In-Depth Interview Guide cntributes t understanding the scale-up prcess by asking key stakehlders t evaluate what has been achieved in scaleup,

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

PHARYNGO-OESOPHAGECTOMY

PHARYNGO-OESOPHAGECTOMY PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

A fake medicine that passes itself off as a real, authorised medicine. (1)

A fake medicine that passes itself off as a real, authorised medicine. (1) Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces

More information

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram

More information

World Confederation for Physical Therapy Congress , May Singapore

World Confederation for Physical Therapy Congress , May Singapore Wrld Cnfederatin fr Physical Therapy Cngress 2015 1-4, May Singapre Call fr applicatins fr Chair f the Internatinal Scientific Cmmittee The Executive Cmmittee f WCPT invites applicatins and suggestins

More information

during Last Days of Life

during Last Days of Life Unit 36: Supprting Individuals during Last Days f Life Unit reference number: F/616/7374 Level: 3 Unit type: Optinal Credit value: 4 Guided learning hurs: 32 Unit summary Prmting respnsive care in the

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Applying the OSHA Bloodborne Pathogen Standard Chiropractic Setting

Applying the OSHA Bloodborne Pathogen Standard Chiropractic Setting Applying the OSHA Bldbrne Pathgen Standard Chirpractic Setting 1 Pre test 1. Wh is cvered by the OSHA Bldbrne Pathgen Standard? a) A- All emplyees wh culd be reasnably anticipated as a result f perfrming

More information

Anterior Total Hip Arthroplasty Patient Guide & Common Questions

Anterior Total Hip Arthroplasty Patient Guide & Common Questions Intrductin: Anterir Ttal Hip Arthrplasty Patient Guide & Cmmn Questins This handut is a general guide t cmmn indicatins fr anterir ttal hip arthrplasty, what t expect when underging the prcedure, risks,

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery

More information

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone! Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please

More information

Corporate Governance Code for Funds: What Will it Mean?

Corporate Governance Code for Funds: What Will it Mean? Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

Who is eligible for LifeCare? What services are available?

Who is eligible for LifeCare? What services are available? Wh is eligible fr LifeCare? What services are available? LifeCare is an emplyer prvided wrk/life benefit frm The University f Texas at Austin available t all benefits eligible emplyees and their husehld

More information

Administrstrative Procedure

Administrstrative Procedure ELECTRONIC WORKING COPY VERIF. DATE: INITIALS: DIVISION: Envirnment, Safety, Health and Quality FUNCTIONAL AREA: Occupatinal Safety and Health SME: Garrick Schmburg Page 1 f 13 APPROVED BY/DATE: Steve

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.

More information

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program? 3903 Fair Ridge Drive, Suite 209, Fairfax, VA 22033 44121 Harry Byrd Hwy, Suite 285, Ashburn, VA 220147 *Hw did yu hear abut ur prgram? Patient Histry Patient Name: First Middle: Last: Address: City: State:

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

This standard operating procedure applies to stop smoking services provided by North 51.

This standard operating procedure applies to stop smoking services provided by North 51. Authr Name/Title Melanie McIlvar, Bid Develpment Manager Authr Signature Date: 4 th September 2017 Apprver Name/Title Jasn Shelley, Grup Directr f QA/RA Apprver Signature Date: 4 th September 2017 Issue

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Annual Principal Investigator Worksheet About Local Context

Annual Principal Investigator Worksheet About Local Context Cmpleting the NCI CIRB Annual Principal Investigatr Wrksheet Abut Lcal Cntext and the Study-Specific Wrksheet Abut Lcal Cntext at the University f Iwa All investigatrs cnducting research with the Natinal

More information

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair:

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair: Pstperative Anterir Cruciate Ligament Recnstructin Care WITH meniscus repair: Imprtant Phne Numbers: - Please see the cntact infrmatin abve fr imprtant phne numbers t call. - If yu have cncerns after hurs,

More information

EDPS 475: Instructional Objectives for Midterm Exam Behaviorism

EDPS 475: Instructional Objectives for Midterm Exam Behaviorism EDPS 475: Instructinal Objectives fr Midterm Exam Behavirism 1. Given a nvel example t chse frm, identify the characteristics f classical cnditining. General mdel: Stimulus (S) elicits >Respnse (R) Based

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

Name of procedure: Removal of submandibular salivary gland

Name of procedure: Removal of submandibular salivary gland Oral facial surgery Surgical prcedure infrmatin leaflet Name f prcedure: Remval f submandibular salivary gland This leaflet explains sme f the benefits, risks and alternatives t the peratin. We want yu

More information

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Tick fever is a cattle disease caused by any one of the following blood parasites:

Tick fever is a cattle disease caused by any one of the following blood parasites: Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus

More information

Fee Schedule - Home Health Care- 2015

Fee Schedule - Home Health Care- 2015 Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule

More information

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:

More information

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1 State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

Memory Care Community Standards

Memory Care Community Standards Memry Care Cmmunity Standards SEXUAL / INTIMATE BEHAVIOR POLICY Staff shuld understand, recgnize and supprt the healthful expressin f sexuality and intimacy amng residents, and demnstrate an understanding

More information

Memory Screening Site s PROGRAM HANDBOOK

Memory Screening Site s PROGRAM HANDBOOK Memry Screening Site s PROGRAM HANDBOOK 866-232-8484 www.alzfdn.rg/memry-screening/ Table f Cntents Page 3 Page 5 Page 6 Page 7 Page 8 Page 10 Page 12 Page 13 All Abut the Natinal Memry Screening Prgram

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Annual Assembly Abstract Review Process

Annual Assembly Abstract Review Process Annual Assembly Abstract Review Prcess AAHPM and HPNA cllabrate t review and select abstracts fr Annual Assembly. The cmmittees meet prir t the calls t review and update the Assembly bjectives (Planning

More information

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant

More information

Ministry of Health and Long-Term Care

Ministry of Health and Long-Term Care Ministry f Health and Lng-Term Care Infrmatin n Nvel H1N1 Influenza A - Frequently Asked Questins fr Primary Care Practitiners May 7, 2009 This infrmatin is subject t change based n evlving infrmatin n

More information

AUTHORISED BY: CEO. Introduction. Whistle Blowing

AUTHORISED BY: CEO. Introduction. Whistle Blowing GUIDELINE NAME: Field Cmplaints Disclsure Guidelines SECTION : Refer t Excel Guidelines list Dcument N: DISTRIBUTION: All Emplyees FIRST ISSUED: April 2013 DATE UPDATED: Dec 2014 ISSUED/UPDATED BY: Peple

More information

DRAFT Policy for the Management of Ear Wax

DRAFT Policy for the Management of Ear Wax Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary Unit 11: Understand Mental Ill Health Unit reference number: L/616/7295 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 16 Unit summary Mental ill health culd be ne f the mst serius health

More information

Appendix 1 Example of Homely Remedy Policy

Appendix 1 Example of Homely Remedy Policy Appendix 1 Example f Hmely Remedy Plicy Hmely Remedy Plicy - EXAMPLE This plicy applies t (insert name f Care Hme) Definitin A hmely (r husehld) remedy is a medicinal prduct fr the shrt-term treatment

More information

ESCHERICHIA COLI O157:H7

ESCHERICHIA COLI O157:H7 Fact Sheet N 125 July 1996 ESCHERICHIA COLI O157:H7 1. What is Escherichia cli O157:H7? Escherichia cli is a bacterium that is a cmmn inhabitant f the gut f warm blded animals, including man. Mst strains

More information

77 WHO/IPA workshop on Immunisation

77 WHO/IPA workshop on Immunisation 77 WHO/IPA wrkshp n Immunisatin cst/efficacy f either f them des nt justify their rutine use. Cntents f such diseases shuld be within the respnsibilities f the Epidemilgy Department. XVII INTERNATIONAL

More information